Physical activity in the treatment of obesity

Česká verzia

Authors: H. Svačinová ¹; M. Matoulek ²
Authors place of work: Klinika tělovýchovného lékařství a rehabilitace Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MU Dr. Petr Dobšák, CSc. ¹; III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MU Dr. Štěpán Svačina, DrSc., MBA ²
Published in the journal: Vnitř Lék 2010; 56(10): 1069-1073
Category: Obesity 2010

Summary

Physical activity is a pivotal component in the treatment of obesity. An increase in energy expenditure through physical activity in combination with a weight reduction diet intensifies negative energy balance, brings a reduction in fat reserves and, simultaneously, prevents loss of an active body mass. The main aim and significance of physical activity in obese individuals is not the weight reduction itself but its positive effects on factors that represent an increased cardiovascular risk. When prescribing a physical activity to an obese individual, selection of a suitable form, intensity, duration and frequency of load should all be considered. Patient cooperation represents an essential factor in the success of a therapy involving physical activity and is concurrently affected by the presence of other obesity complicating diseases. Also important are other negative factors determined by real life: lack of time, lack of support from family and others, bad weather, inaccessibility of suitable equipment or space or aversion to physical activity as such. When these circumstances are overcome, positively motivating reasoning has to be provided. Communication between physicians and non‑medical professional community is the only way to influence physical activity of obese patients and minimise adverse effects. Significant increase in physical activity of the entire population is determined by modifications in physical and social environment and revision of healthcare policy.

Key words:
physical activity – obesity – energy expenditure – fat tissue

Zdroje

1. Wilmore JH, Stanforth PR, Hudspeth LA et al. Alterations in resting metabolic rate as a consequence of 20 wk of endurance training: the HERITAGE Family Study. Am J Clin Nutr 1998; 68: 66– 71.

2. Ballor DL, Poehlman ET. A meta‑analysis of the effects of exercise and/ or dietary restriction on resting metabolic rate. Eur J Appl Physiol Occup Physiol 1995; 71: 535– 542.

3. Štich V. Pohybová aktivita v prevenci a léčbě obezity. In: Hainer V et al (eds). Základy klinické obezitologie. Praha: Grada Publishing 2004.

4. Ross R, Janssen I. Physical activity, total and regional obesity: dose‑response considerations. Med Sci Sports Exerc 2001; 33 (Suppl 6): S521– S526.

5. Grundy SM, Blackburn G, Higgins M et al. Physical activity in the prevention and treatment of obesity and its comorbidities. Med Sci Sports Exerc 1999; 31 (Suppl 11): S502– S508.

6. Wing RR. Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 31 (Suppl 11): S547– S552.

7. Fogelholm M, Kukkonen- Harjula K. Does physical activity prevent weight gain – a systematic review. Obes Rev 2000; 1: 95– 111.

8. Máčková J, Máček M. Klinický význam tělesné zátěže v prevenci a léčení metabolického syndromu. Med Sport Boh Slov 1995; 4: 103– 106.

9. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all cause and cardiovascular disease mortality in men. Am J Clin Nutr 1999; 69: 373– 380.

10. Duncan GE, Perri MG, Theriaque DW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 2003; 26: 557– 562.

11. Lehmann R, Vokac A, Niedermann K et al. Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 1995; 38: 1313– 1319.

12. Yamanouchi K, Shinozaki T, Chikada Ket al. Daily walking combined with diet therapy is useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 1995; 18: 775– 778.

13. Han TS, van Leer EM, Seidell LC et al. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. Br Med J 1995; 311: 1401– 1405.

14. Svačina Š. Obezita a diabetes. Praha: Maxdorf 2000.

15. Kelley DE, Goodpaster BH. Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc 1999; 31 (Suppl 11): S619– S623.

16. Svačinová H. Role pohybové léčby a tělesné zdatnosti v prevenci a léčbě metabolického syndromu. Vnitř Lék 2005; 51: 87– 92.

17. Svačinová H, Olšovský J, Žáčková V et al. Vliv tréninku chůzí na aerobní kapacitu a krevní lipidy u diabetiků 2. typu. Vnitř Lék 2003; 49: 205– 209.

18. Matoulek M. Fyzická aktivita v léčbě metabolického syndromu. In: Svačina Š et al (eds). Metabolický syndrom. Praha: Triton 2006: 211– 217.

19. Placheta Z et al. Zátěžové vyšetření a pohybová léčba ve vnitřním lékařství. Brno: MU 2001.

20. McGavock J, Mandic S, Lewanaczuk RZ et al. Exercise training improves cardiorespiratory fitness and endothelial function in women with type 2 diabetes. Abstracts 18th International Diabetes Federation Congress. Paris: August 24.– 29. 2003.

21. Máček M, Máčková J. Může pravidelná pohybová aktivita prodloužit život? Med Sport Boh Slov 1999; 8: 65– 71.

22. Laukkanen JA, Lakka TA, Rauramaa R et al. Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med 2001; 161: 825– 831.

23. Jakicic JM, Otto AD. Physical consideration for the treatment and prevention of obesity. Am J Clin Nutr 2005; 82 (Suppl): 226S– 229S.

24. ACSM (American College of Sports Medicine). Exercise and type 2 Diabetes. Position Stand Med Sci Sports Exerc 2000; 7: 1345– 1360.

25. Rosolová H. Deprese a metabolický syndrom. In: Svačina Š et al (eds). Metabolický syndrom. Praha: Triton 2006: 166– 168.

26. Dunn AL, Marcus BH, Kampert JB et al. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA 1999; 281: 327– 334.

27. Andersen RE, Wadden TA, Bartlett SJ et al. Effects of lifestyle activity vs. structures aerobic exercise in obese woman: a randomized trial. JAMA 1999; 281: 335– 340.

28. Provazník K, Komárek L. Prevence v primární péči: doporučené postupy WHO. Praha: Státní zdravotní ústav 1997.

29. Matoulek M. Stanovení intenzity fyzické aktivity u obézních diabetiků. Vnitř Lék 2007; 53: 560– 562.

30. Špác J. Je současný tělesný trénink nezbytnou součástí léčby chronické ICHS i v 21. století? Vnitř Lék 2005; 51: 930– 933.

31. Radvanský J. Má metabolický syndrom odpočívat v pokoji? Nemá – je to nejlepší cesta k pochopení benefitu tělesné zátěže pro většinu jeho nositelů. Med Sport Boh Slov 2006; 15: 130– 137.